Advertisement

Ads Placeholder
Loading...

NanoRepro AG

NNGRF•PNK
Healthcare
Medical - Diagnostics & Research
$12.76
$0.00(0.00%)
U.S. Market opens in 58h 2m

NanoRepro AG (NNGRF) Stock Overview

Explore NanoRepro AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap164.3M
P/E Ratio-68.29
EPS (TTM)$0.21
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$12.67

NNGRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NanoRepro AG (NNGRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $12.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -68.29 and a market capitalization of 164.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.nanorepro.com
49 6421 951449
Untergasse 8, Marburg, NaN, 35037

Company Facts

170 Employees
IPO DateMar 2, 2021
CountryDE

Frequently Asked Questions